Access cutting-edge her2+ metastatic breast cancer (mbc) treatment through this clinical trial at a research site in Durham. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Durham location
Preparing your pre-screening questions…
Access her2+ metastatic breast cancer (mbc) specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related her2+ metastatic breast cancer (mbc) treatment provided free
Check if you qualify for this her2+ metastatic breast cancer (mbc) clinical trial in Durham, NC
No-Cost Study Care
Local to Durham
Convenient for NC residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The goal of this study is to test a novel nurse-delivered patient navigation program for women with HER2+ metastatic breast cancer (mBC) receiving tucatinib, trastuzumab, and capecitabine. The program will focus on enhancing understanding of the treatment regimen, managing symptoms and adherence, and improving coping and self-management skills. If successful, the program could be integrated into clinical care to better support mBC patients. The main question the study aims to answer is: is the patient navigation program feasible and acceptable for mBC patients? Participants will receive patient navigation sessions over about 6 weeks. Participants will also complete study assessments via electronic survey at baseline and at about 3 and 6 weeks after enrollment, with the last assessment occurring after completion of the patient navigation program sessions. Participants will also complete a post-program exit interview.
Sponsor: Duke University
Yes, this clinical trial (NCT06983691) has an active research site in Durham, NC that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for her2+ metastatic breast cancer (mbc) treatment options in Durham, NC, this clinical trial (NCT06983691) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Durham research site is actively enrolling participants for this clinical trial. You'll receive care from experienced her2+ metastatic breast cancer (mbc) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all her2+ metastatic breast cancer (mbc) clinical trials near you to find additional studies recruiting in your area.
See all breast cancer clinical trials recruiting in Durham — not just this study.
Browse Breast Cancer Trials in Durham →